期刊文献+

宫颈癌中HPV16感染与IL-6表达的关系 被引量:7

Relationship between HPV16 Infection and IL-6 Expression in Cervical Carcinoma
下载PDF
导出
摘要 目的探讨IL-6在宫颈病变中的表达及其与癌浸润转移的关系,探讨宫颈病变组织中HPV16DNA的表达及临床意义,探索两者之间的关系。方法采用免疫组织化学SP法检测了40例宫颈鳞状细胞癌(CSCC)、38例CINⅢ、28例CINⅠ~Ⅱ和15例正常宫颈组织中IL-6的表达;采用原位杂交法检测各组中HPV16DNA的表达。结果IL-6在正常对照组、CINⅠ~Ⅱ组、CINⅢ组和CSCⅣ组阳性率分别为46.7%(7/15)、71.4%(20/28)、81.6%(31/38)、87.5%(35/40),CSCC组的表达高于正常对照组及CIN1-2组(P<0.05),且与临床分期和病理分级无关,但与淋巴结转移有关;上述各组中HPV16DNA阳性表达率分别为6.7%(1/15)、25%(7/28)、65.8%(25/38)、80%(32/40),各组明显高于正常对照组(P<0.05);CINⅢ组明显高于CINⅠ~Ⅱ组(P<0.05);HPV16DNA的表达与CSCC临床分期、病理分级及淋巴结转移无关;IL-6和HPV16DNA表达呈正相关(rs=0.756,P<0.05)。结论IL-6在CSCC中的高表达与宫颈癌的侵袭性行为有关,可作为判断早期宫颈癌预后的指标;IL-6和HPV16感染呈正相关,二者可能协同作用导致宫颈癌的恶性发展。 Objective To study the expression of interleukin-6 (IL-6) in cervical carcinoma and its relationship with invasion and metastasis and explore the expression of HPV16 DNA in cervical disease and the correlation of IL-6 with HPV16 infection. Methods The expression of IL-6 in 40 cases of CSCC, 38 cases of CIN3, 28 cases of CIN Ⅰ-Ⅱ, 15 cases of normal cervical epithelium was detected by immunohistochemical SP method, and the expression of HPV16 DNA in the four groups were detected by in situ hybridization. Results The positive rate of IL-6 in normal cervical epithelium, CIN Ⅰ-Ⅱ, CINⅢand CSCC was 46. 7% (7/15), 71.4% (20/28), 81.6% (31/38), 87. 5% (35/40) respectively. The positive rate of IL-6 in CSCC was significantly higher than in normal controls and CIN Ⅰ-Ⅱ (P(0. 05). The expression of IL-6 was not associated with clinic stage and histological grade, but to metastasis of lymph node. The positive rate of HPV16 DNA in normal cervical epithelium, CIN Ⅰ-Ⅱ , CIN Ⅲ and CSCC was 6. 7%(1/15), 25 % (7/28) , 65. 8% (25/38) and 80% (32/40), respectively, and that was significantly higher in other three group than in normal controls. There was significant difference between CIN Ⅲand CIN Ⅰ-Ⅱ. The expression of HPV16 DNA was not associated with clinic stage, histological grade and metastasis of lymph node. The expression of IL-6 was positively related to HPV16 DNA (rs = 0. 756, P〈0. 05). Conclusion The high expression of IL-6 in CSCC might be correlated with invasive behavior of cervical carcinoma, and IL-6 might become a useful prognostic indicators for early cervical carcinoma. IL-6 was positively related to HPV16 infection in CSCC, and their synergistic reaction might lead to the development of cervical carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第1期77-80,共4页 Cancer Research on Prevention and Treatment
关键词 子宫颈肿瘤 鳞状细胞癌 IL-6 HPV16 Cervical neoplasms Squamous cell carcinoma IL-6 HPV16
  • 相关文献

参考文献10

  • 1Jastreboff AM,Cymet T. Role of the human papilloma virus in the development of cervical intraepithelial neoplasis and malignancy[J]. Postgrad Med J, 2002,78 (918) : 225- 228.
  • 2Wei LH, Kuo ML, Chen CA, et al. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI3-K/Akt pathway[J]. Oncogene, 2001,20(41 ) :5799-5809.
  • 3Oastrilli G, Tatone D, Diodoro MG, et-al. Interleukin lalpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells[J]. Br J Cancer, 1997,75(6) :855 859.
  • 4Wei LH, Kuo ML, Chen CA, et al. Interleukin 6 in cervical cancer: the relationship with vascular endothelial growth factor[J]. Gynecol Oncol. 2001, 82( 1 ) : 49-56.
  • 5MobergM, Gustavsson I, Gyllensten U. Type specific associations of human papilloma virus load with risk of developing cervical carcinoma in situ[J]. Int J, 2004, 112(5) : 854- 859.
  • 6Altiok S. Molecular markers in cervical cytology[J]. Clin Lab Med. 2003, 23(3): 709-728.
  • 7贾英,吴瑾,唐良萏.HPV16 E7和Brn-3a在宫颈癌前病变中的表达及其意义[J].肿瘤防治研究,2006,33(8):568-571. 被引量:5
  • 8Smith PC, Keller ET. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice[J]. Prostate,2001.48(1 ) :47- 53.
  • 9Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti inter-leukin-6 receptor antibody treatment of multicentric Castleman disease[J]. Blood, 2005. 106(8) :2627-2632.
  • 10王小兵,李茉,刘朝阳,田海梅,曲平,李艳芬,刘毅,曹冬艳,粱智,程冬婉,邵长君,张伟.HPV16Z-Hsp65-E6/E7无佐剂重组蛋白疫苗的研究[J].中国肿瘤生物治疗杂志,2006,13(1):8-12. 被引量:7

二级参考文献20

  • 1Wu QJ,Guo M,Lu ZM,et al.Detection of human papillomavirus-16 in ovarian malignancy[J].Br J Cancer,2003,89(4):672-675.
  • 2Lin KY,Guarnieri G,Wu TC,et al.Treatment of established tumors with a novel vaccine that enhances major histocompatibility class Ⅱ presentation of tumor antigen[J].Cancer Res,1996,56(1):21-26.
  • 3van der Berg SH,Kwanppenberg KM,O'Neill T,et al.Pre-clinical safety and efficacy of TA-CIN,a recombinant HPV16 L2E6E7fusion protein vaccine,in homologous and heterologus prime-boost regimens[J].Vaccine,2001,19(21):3652-3660.
  • 4Chu NR,Wu HB,Wu TC,et al.Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising mycobacterium bovis bacilli calmette gue rin (BCG) hsp65 and HPV16 E7[J].Clin Exp Immunol,2000,121 (2):216-225.
  • 5de Jong A,O'Neill T,Khan Y,et al.Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN,an HPV16L2E7 E6 fusion protein vaccine[J].Vaccine,2002,20 (29-30):3456-3464.
  • 6Anthony LS,Wu H,Sweet H,et al.Priming of CD81 CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule[J].Vaccine,1999,17 (4):373 -383.
  • 7Suzue K,Zhou XX,Eisen HN,et al.Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class Ⅰ presentation pathway[J].Proc Natl Acad Sci USA,1997,94(24):13146-13151.
  • 8Yamazaki K,Nguyen T,Podack ER.Cutting edge:Tumor secreted heat shock-fusion protein elicits CD8 cells for rejection[J].J Immunol,1999,163(9):5178 -5182.
  • 9Huang Q,Richmond JFL,Suzue K,et al.In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4(1) T cell independent[J].J Exp Med,2000,191(2):403-408.
  • 10Cho BK,Palliser D,Guillen E,et al.A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins[J].Immunolgy,2000,12(3):263-272.

共引文献10

同被引文献72

  • 1鲁选文,肖长义,叶红.细胞因子与人类乳头瘤病毒及宫颈癌相关性的研究进展[J].中华临床医师杂志(电子版),2011,5(14):4163-4166. 被引量:6
  • 2李淑敏,章文华,吴令英,赵芳辉,黄曼妮,李楠,陈凤.人乳头状瘤病毒负荷量与子宫颈癌及其癌前病变关系的初步研究[J].中华妇产科杂志,2004,39(6):400-402. 被引量:76
  • 3陶晓峰,王齐敏,金晓明.肝细胞癌中Ezrin、Moesin表达的临床病理学意义[J].临床与实验病理学杂志,2007,23(1):30-32. 被引量:22
  • 4Sauv6 S, Tremblay L, Lavigne P. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors[J]. J Mol Biol,2004,342(3) : 813-832.
  • 5Herndndez-Hernandez DM, Omelas-Bemal L, Guido-Jimenez M,et al. Association between high-risk human Papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women[J]. Gynecol Oncol, 2003,90 (2) : 310-317.
  • 6Venturoli S,Cricca M, Bonvicini F, et al. Human papillomavirus DNA testing by PCR-ELISA and hybrid capture Ⅱ from a single cytological specimen: concordance and correlation with cytological resul[J]. J Clin Virol, 2002,25 (2) : 177-185.
  • 7Jastreboff A M, Cymet T. Role of the human papilloma virus in the development of cervical intraepithelial neoplasis and malignancy[J]. Postgrad Med J ,2002 ,78 (918) : 225 -228.
  • 8Martin T A,Harrison G,Mansel R E,et al. The role of the CD44/ezrin complex in cancer metastasis [ J ]. Crit Rev Oncol Hematol,2003,46 (2) : 165 -186.
  • 9Pujuguet P, Del Maestro L,Cautreau A,et al. Ezrln regulates E - cadherin - dependent adherence junction assembly through Racl activation [ J ].Mol Biol Cell, 2003,14 (5) :2181-2191.
  • 10Lugini L, Lozupone F, Matarrese P, et al. Potent phagocytic activity discriminate metastatic and primary human malignat melanoma :a key role of ezrin[J]. Lab Invest, 2003,83 : 1555-1567.

引证文献7

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部